Skip to contentUden Stephen — Rallybio Corp insider: 16 transactions · InsiderLensUden Stephen
- Director at Rallybio Corp · on record since Feb 16, 2024
- Chief Executive Officer at Rallybio Corp · on record since Jul 29, 2021
- Exec VP, Research & Developmen at NEUROGEN CORP · on record since Dec 20, 2005
Insider trading activity of Uden Stephen
- Transactions on record
- 16
- since Dec 20, 2005
- Open-market buys
- 3
- $98.5K
- Open-market sells
- 0
- Companies traded
- 2
- last filing Feb 19, 2025
Figures computed from official regulatory filings — methodology.
Companies where Uden Stephen has traded
Track record of Uden Stephen
Insufficient history for a statistical track record (fewer than 5 open-market buys).
Transaction history of Uden Stephen
Co-insiders of Uden Stephen
This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →
Baker Biotech Capital III (GP), LLCNEUROGEN CORP
| Company | Filed | Type | Qty | Price | Value · USD | Src |
|---|
| Feb 19, 2025 | AwardD | 453,700 | 0.00 USD | $0 | SEC |
| Feb 16, 2024 | AwardD | 216,000 | 0.00 USD | $0 | SEC |
| Feb 6, 2023 | AwardD | 214,000 | 0.00 USD | $0 | SEC |
| Feb 9, 2022 | AwardD | 62,000 | 0.00 USD | $0 | SEC |
| Jan 14, 2022 | AwardD | 160,000 | 0.00 USD | $0 | SEC |
| Jan 14, 2022 | Buy | 5,000 | 10.55 USD | $52.8K | SEC |
| Jan 14, 2022 | Buy | 4,193 | 9.06 USD | $38K | SEC |
| Jan 14, 2022 | Buy | 807 | 9.62 USD | $7.8K | SEC |
| Jan 14, 2022 | OtherD | -100,000 | — | — | SEC |
| Jan 14, 2022 | OtherD | -150,000 | — | — | SEC |
| Jan 14, 2022 | Other | 709,127 | — | — | SEC |
| Jan 14, 2022 | OtherD | -107,891 | — | — | SEC |
| Jan 14, 2022 | OtherD | -4,820,000 | — | — | SEC |
| Jan 19, 2007 | AwardD | 90,000 | 0.00 | $0 | SEC |
| Dec 19, 2006 | AwardD | 36,400 | 0.00 | $0 | SEC |
| Dec 20, 2005 | AwardD | 15,840 | 0.00 USD | — | SEC |